1 Market Overview 1.1 Product Overview and Scope of IFNG(Protein) 1.2 Classification of IFNG(Protein) by Type 1.2.1 Overview: Global IFNG(Protein) Market Size by Type: 2020 Versus 2021 Versus 2026 1.2.2 Global IFNG(Protein) Revenue Market Share by Type in 2020 1.2.3 Above 95% 1.2.4 Above 99% 1.2.5 Others 1.3 Global IFNG(Protein) Market by Application 1.3.1 Overview: Global IFNG(Protein) Market Size by Application: 2020 Versus 2021 Versus 2026 1.3.2 Biopharmaceutical Companies 1.3.3 Hospitals 1.3.4 Bioscience Research Institutions 1.3.5 Others 1.4 Global IFNG(Protein) Market Size & Forecast 1.5 Global IFNG(Protein) Market Size and Forecast by Region 1.5.1 Global IFNG(Protein) Market Size by Region: 2016 VS 2021 VS 2026 1.5.2 Global IFNG(Protein) Market Size by Region, (2016-2021) 1.5.3 North America IFNG(Protein) Market Size and Prospect (2016-2026) 1.5.4 Europe IFNG(Protein) Market Size and Prospect (2016-2026) 1.5.5 Asia-Pacific IFNG(Protein) Market Size and Prospect (2016-2026) 1.5.6 South America IFNG(Protein) Market Size and Prospect (2016-2026) 1.5.7 Middle East and Africa IFNG(Protein) Market Size and Prospect (2016-2026) 1.6 Market Drivers, Restraints and Trends 1.6.1 IFNG(Protein) Market Drivers 1.6.2 IFNG(Protein) Market Restraints 1.6.3 IFNG(Protein) Trends Analysis 2 Company Profiles 2.1 Thermo Fisher Scientific 2.1.1 Thermo Fisher Scientific Details 2.1.2 Thermo Fisher Scientific Major Business 2.1.3 Thermo Fisher Scientific IFNG(Protein) Product and Solutions 2.1.4 Thermo Fisher Scientific IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans 2.2 Bio-Rad 2.2.1 Bio-Rad Details 2.2.2 Bio-Rad Major Business 2.2.3 Bio-Rad IFNG(Protein) Product and Solutions 2.2.4 Bio-Rad IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.2.5 Bio-Rad Recent Developments and Future Plans 2.3 Lifespan Biosciences 2.3.1 Lifespan Biosciences Details 2.3.2 Lifespan Biosciences Major Business 2.3.3 Lifespan Biosciences IFNG(Protein) Product and Solutions 2.3.4 Lifespan Biosciences IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.3.5 Lifespan Biosciences Recent Developments and Future Plans 2.4 R&D Systems 2.4.1 R&D Systems Details 2.4.2 R&D Systems Major Business 2.4.3 R&D Systems IFNG(Protein) Product and Solutions 2.4.4 R&D Systems IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.4.5 R&D Systems Recent Developments and Future Plans 2.5 Genetex 2.5.1 Genetex Details 2.5.2 Genetex Major Business 2.5.3 Genetex IFNG(Protein) Product and Solutions 2.5.4 Genetex IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.5.5 Genetex Recent Developments and Future Plans 2.6 Abbexa Ltd 2.6.1 Abbexa Ltd Details 2.6.2 Abbexa Ltd Major Business 2.6.3 Abbexa Ltd IFNG(Protein) Product and Solutions 2.6.4 Abbexa Ltd IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.6.5 Abbexa Ltd Recent Developments and Future Plans 2.7 Biobyt 2.7.1 Biobyt Details 2.7.2 Biobyt Major Business 2.7.3 Biobyt IFNG(Protein) Product and Solutions 2.7.4 Biobyt IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.7.5 Biobyt Recent Developments and Future Plans 2.8 Stemcell 2.8.1 Stemcell Details 2.8.2 Stemcell Major Business 2.8.3 Stemcell IFNG(Protein) Product and Solutions 2.8.4 Stemcell IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.8.5 Stemcell Recent Developments and Future Plans 2.9 Boster Bio 2.9.1 Boster Bio Details 2.9.2 Boster Bio Major Business 2.9.3 Boster Bio IFNG(Protein) Product and Solutions 2.9.4 Boster Bio IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.9.5 Boster Bio Recent Developments and Future Plans 2.10 Aviva Systems Biology 2.10.1 Aviva Systems Biology Details 2.10.2 Aviva Systems Biology Major Business 2.10.3 Aviva Systems Biology IFNG(Protein) Product and Solutions 2.10.4 Aviva Systems Biology IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.10.5 Aviva Systems Biology Recent Developments and Future Plans 2.11 Atlas Antibodies 2.11.1 Atlas Antibodies Details 2.11.2 Atlas Antibodies Major Business 2.11.3 Atlas Antibodies IFNG(Protein) Product and Solutions 2.11.4 Atlas Antibodies IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.11.5 Atlas Antibodies Recent Developments and Future Plans 2.12 ProteoGenix 2.12.1 ProteoGenix Details 2.12.2 ProteoGenix Major Business 2.12.3 ProteoGenix IFNG(Protein) Product and Solutions 2.12.4 ProteoGenix IFNG(Protein) Revenue, Gross Margin and Market Share (2019-2021) 2.12.5 ProteoGenix Recent Developments and Future Plans 3 Market Competition, by Players 3.1 Global IFNG(Protein) Revenue and Share by Players (2019-2021) 3.2 Market Concentration Rate 3.2.1 Top 3 IFNG(Protein) Players Market Share 3.2.2 Top 10 IFNG(Protein) Players Market Share 3.2.3 Market Competition Trend 3.3 IFNG(Protein) Players Head Office, Products and Services Provided 3.4 Mergers & Acquisitions 3.5 New Entrants and Expansion Plans 4 Market Size Segment by Type 4.1 Global IFNG(Protein) Revenue and Market Share by Type (2016-2021) 4.2 Global IFNG(Protein) Market Forecast by Type (2021-2026) 5 Market Size Segment by Application 5.1 Global IFNG(Protein) Revenue Market Share by Application (2016-2021) 5.2 IFNG(Protein) Market Forecast by Application (2021-2026) 6 North America by Country, by Type, and by Application 6.1 North America IFNG(Protein) Revenue by Type (2016-2026) 6.2 North America IFNG(Protein) Revenue by Application (2016-2026) 6.3 North America IFNG(Protein) Market Size by Country 6.3.1 North America IFNG(Protein) Revenue by Country (2016-2026) 6.3.2 United States IFNG(Protein) Market Size and Forecast (2016-2026) 6.3.3 Canada IFNG(Protein) Market Size and Forecast (2016-2026) 6.3.4 Mexico IFNG(Protein) Market Size and Forecast (2016-2026) 7 Europe by Country, by Type, and by Application 7.1 Europe IFNG(Protein) Revenue by Type (2016-2026) 7.2 Europe IFNG(Protein) Revenue by Application (2016-2026) 7.3 Europe IFNG(Protein) Market Size by Country 7.3.1 Europe IFNG(Protein) Revenue by Country (2016-2026) 7.3.2 Germany IFNG(Protein) Market Size and Forecast (2016-2026) 7.3.3 France IFNG(Protein) Market Size and Forecast (2016-2026) 7.3.4 United Kingdom IFNG(Protein) Market Size and Forecast (2016-2026) 7.3.5 Russia IFNG(Protein) Market Size and Forecast (2016-2026) 7.3.6 Italy IFNG(Protein) Market Size and Forecast (2016-2026) 8 Asia-Pacific by Region, by Type, and by Application 8.1 Asia-Pacific IFNG(Protein) Revenue by Type (2016-2026) 8.2 Asia-Pacific IFNG(Protein) Revenue by Application (2016-2026) 8.3 Asia-Pacific IFNG(Protein) Market Size by Region 8.3.1 Asia-Pacific IFNG(Protein) Revenue by Region (2016-2026) 8.3.2 China IFNG(Protein) Market Size and Forecast (2016-2026) 8.3.3 Japan IFNG(Protein) Market Size and Forecast (2016-2026) 8.3.4 South Korea IFNG(Protein) Market Size and Forecast (2016-2026) 8.3.5 India IFNG(Protein) Market Size and Forecast (2016-2026) 8.3.6 Southeast Asia IFNG(Protein) Market Size and Forecast (2016-2026) 8.3.7 Australia IFNG(Protein) Market Size and Forecast (2016-2026) 9 South America by Country, by Type, and by Application 9.1 South America IFNG(Protein) Revenue by Type (2016-2026) 9.2 South America IFNG(Protein) Revenue by Application (2016-2026) 9.3 South America IFNG(Protein) Market Size by Country 9.3.1 South America IFNG(Protein) Revenue by Country (2016-2026) 9.3.2 Brazil IFNG(Protein) Market Size and Forecast (2016-2026) 9.3.3 Argentina IFNG(Protein) Market Size and Forecast (2016-2026) 10 Middle East & Africa by Country, by Type, and by Application 10.1 Middle East & Africa IFNG(Protein) Revenue by Type (2016-2026) 10.2 Middle East & Africa IFNG(Protein) Revenue by Application (2016-2026) 10.3 Middle East & Africa IFNG(Protein) Market Size by Country 10.3.1 Middle East & Africa IFNG(Protein) Revenue by Country (2016-2026) 10.3.2 Turkey IFNG(Protein) Market Size and Forecast (2016-2026) 10.3.3 Saudi Arabia IFNG(Protein) Market Size and Forecast (2016-2026) 10.3.4 UAE IFNG(Protein) Market Size and Forecast (2016-2026) 11 Research Findings and Conclusion 12 Appendix 12.1 Methodology 12.2 Research Process and Data Source 12.3 Disclaimer
List of Tables Table 1. Global IFNG(Protein) Revenue by Type, (USD Million), 2020 VS 2021 VS 2026 Table 2. Global IFNG(Protein) Revenue by Application, (USD Million), 2020 VS 2021 VS 2026 Table 3. Global Market IFNG(Protein) Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026) Table 4. Global IFNG(Protein) Revenue (USD Million) by Region (2016-2021) Table 5. Global IFNG(Protein) Revenue Market Share by Region (2021-2026) Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors Table 7. Thermo Fisher Scientific Major Business Table 8. Thermo Fisher Scientific IFNG(Protein) Product and Solutions Table 9. Thermo Fisher Scientific IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 10. Bio-Rad Corporate Information, Head Office, and Major Competitors Table 11. Bio-Rad Major Business Table 12. Bio-Rad IFNG(Protein) Product and Solutions Table 13. Bio-Rad IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 14. Lifespan Biosciences Corporate Information, Head Office, and Major Competitors Table 15. Lifespan Biosciences Major Business Table 16. Lifespan Biosciences IFNG(Protein) Product and Solutions Table 17. Lifespan Biosciences IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 18. R&D Systems Corporate Information, Head Office, and Major Competitors Table 19. R&D Systems Major Business Table 20. R&D Systems IFNG(Protein) Product and Solutions Table 21. R&D Systems IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 22. Genetex Corporate Information, Head Office, and Major Competitors Table 23. Genetex Major Business Table 24. Genetex IFNG(Protein) Product and Solutions Table 25. Genetex IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 26. Abbexa Ltd Corporate Information, Head Office, and Major Competitors Table 27. Abbexa Ltd Major Business Table 28. Abbexa Ltd IFNG(Protein) Product and Solutions Table 29. Abbexa Ltd IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 30. Biobyt Corporate Information, Head Office, and Major Competitors Table 31. Biobyt Major Business Table 32. Biobyt IFNG(Protein) Product and Solutions Table 33. Biobyt IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 34. Stemcell Corporate Information, Head Office, and Major Competitors Table 35. Stemcell Major Business Table 36. Stemcell IFNG(Protein) Product and Solutions Table 37. Stemcell IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 38. Boster Bio Corporate Information, Head Office, and Major Competitors Table 39. Boster Bio Major Business Table 40. Boster Bio IFNG(Protein) Product and Solutions Table 41. Boster Bio IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 42. Aviva Systems Biology Corporate Information, Head Office, and Major Competitors Table 43. Aviva Systems Biology Major Business Table 44. Aviva Systems Biology IFNG(Protein) Product and Solutions Table 45. Aviva Systems Biology IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 46. Atlas Antibodies Corporate Information, Head Office, and Major Competitors Table 47. Atlas Antibodies Major Business Table 48. Atlas Antibodies IFNG(Protein) Product and Solutions Table 49. Atlas Antibodies IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 50. ProteoGenix Corporate Information, Head Office, and Major Competitors Table 51. ProteoGenix Major Business Table 52. ProteoGenix IFNG(Protein) Product and Solutions Table 53. ProteoGenix IFNG(Protein) Revenue (USD Million), Gross Margin and Market Share (2019-2021) Table 54. Global IFNG(Protein) Revenue (USD Million) by Players (2019-2021) Table 55. Global IFNG(Protein) Revenue Share by Players (2019-2021) Table 56. Breakdown of IFNG(Protein) by Company Type (Tier 1, Tier 2 and Tier 3) Table 57. IFNG(Protein) Players Head Office, Products and Services Provided Table 58. IFNG(Protein) Mergers & Acquisitions in the Past Five Years Table 59. IFNG(Protein) New Entrants and Expansion Plans Table 60. Global IFNG(Protein) Revenue (USD Million) by Type (2016-2021) Table 61. Global IFNG(Protein) Revenue Share by Type (2016-2021) Table 62. Global IFNG(Protein) Revenue Forecast by Type (2021-2026) Table 63. Global IFNG(Protein) Revenue by Application (2016-2021) Table 64. Global IFNG(Protein) Revenue Forecast by Application (2021-2026) Table 65. North America IFNG(Protein) Revenue by Type (2016-2021) & (USD Million) Table 66. North America IFNG(Protein) Revenue by Type (2021-2026) & (USD Million) Table 67. North America IFNG(Protein) Revenue by Application (2016-2021) & (USD Million) Table 68. North America IFNG(Protein) Revenue by Application (2021-2026) & (USD Million) Table 69. North America IFNG(Protein) Revenue by Country (2016-2021) & (USD Million) Table 70. North America IFNG(Protein) Revenue by Country (2021-2026) & (USD Million) Table 71. Europe IFNG(Protein) Revenue by Type (2016-2021) & (USD Million) Table 72. Europe IFNG(Protein) Revenue by Type (2021-2026) & (USD Million) Table 73. Europe IFNG(Protein) Revenue by Application (2016-2021) & (USD Million) Table 74. Europe IFNG(Protein) Revenue by Application (2021-2026) & (USD Million) Table 75. Europe IFNG(Protein) Revenue by Country (2016-2021) & (USD Million) Table 76. Europe IFNG(Protein) Revenue by Country (2021-2026) & (USD Million) Table 77. Asia-Pacific IFNG(Protein) Revenue by Type (2016-2021) & (USD Million) Table 78. Asia-Pacific IFNG(Protein) Revenue by Type (2021-2026) & (USD Million) Table 79. Asia-Pacific IFNG(Protein) Revenue by Application (2016-2021) & (USD Million) Table 80. Asia-Pacific IFNG(Protein) Revenue by Application (2021-2026) & (USD Million) Table 81. Asia-Pacific IFNG(Protein) Revenue by Region (2016-2021) & (USD Million) Table 82. Asia-Pacific IFNG(Protein) Revenue by Region (2021-2026) & (USD Million) Table 83. South America IFNG(Protein) Revenue by Type (2016-2021) & (USD Million) Table 84. South America IFNG(Protein) Revenue by Type (2021-2026) & (USD Million) Table 85. South America IFNG(Protein) Revenue by Application (2016-2021) & (USD Million) Table 86. South America IFNG(Protein) Revenue by Application (2021-2026) & (USD Million) Table 87. South America IFNG(Protein) Revenue by Country (2016-2021) & (USD Million) Table 88. South America IFNG(Protein) Revenue by Country (2021-2026) & (USD Million) Table 89. Middle East & Africa IFNG(Protein) Revenue by Type (2016-2021) & (USD Million) Table 90. Middle East & Africa IFNG(Protein) Revenue by Type (2021-2026) & (USD Million) Table 91. Middle East & Africa IFNG(Protein) Revenue by Application (2016-2021) & (USD Million) Table 92. Middle East & Africa IFNG(Protein) Revenue by Application (2021-2026) & (USD Million) Table 93. Middle East & Africa IFNG(Protein) Revenue by Country (2016-2021) & (USD Million) Table 94. Middle East & Africa IFNG(Protein) Revenue by Country (2021-2026) & (USD Million) List of Figures Figure 1. IFNG(Protein) Picture Figure 2. Global IFNG(Protein) Revenue Market Share by Type in 2020 Figure 3. Above 95% Figure 4. Above 99% Figure 5. Others Figure 6. IFNG(Protein) Revenue Market Share by Application in 2020 Figure 7. Biopharmaceutical Companies Picture Figure 8. Hospitals Picture Figure 9. Bioscience Research Institutions Picture Figure 10. Others Picture Figure 11. Global IFNG(Protein) Revenue, (USD Million): 2020 VS 2021 VS 2026 Figure 12. Global IFNG(Protein) Revenue and Forecast (2016-2026) & (USD Million) Figure 13. Global IFNG(Protein) Revenue Market Share by Region (2016-2026) Figure 14. Global IFNG(Protein) Revenue Market Share by Region in 2020 Figure 15. North America IFNG(Protein) Revenue (USD Million) and Growth Rate (2016-2026) Figure 16. Europe IFNG(Protein) Revenue (USD Million) and Growth Rate (2016-2026) Figure 17. Asia-Pacific IFNG(Protein) Revenue (USD Million) and Growth Rate (2016-2026) Figure 18. South America IFNG(Protein) Revenue (USD Million) and Growth Rate (2016-2026) Figure 19. Middle East and Africa IFNG(Protein) Revenue (USD Million) and Growth Rate (2016-2026) Figure 20. IFNG(Protein) Market Drivers Figure 21. IFNG(Protein) Market Restraints Figure 22. IFNG(Protein) Market Trends Figure 23. Thermo Fisher Scientific Recent Developments and Future Plans Figure 24. Bio-Rad Recent Developments and Future Plans Figure 25. Lifespan Biosciences Recent Developments and Future Plans Figure 26. R&D Systems Recent Developments and Future Plans Figure 27. Genetex Recent Developments and Future Plans Figure 28. Abbexa Ltd Recent Developments and Future Plans Figure 29. Biobyt Recent Developments and Future Plans Figure 30. Stemcell Recent Developments and Future Plans Figure 31. Boster Bio Recent Developments and Future Plans Figure 32. Aviva Systems Biology Recent Developments and Future Plans Figure 33. Atlas Antibodies Recent Developments and Future Plans Figure 34. ProteoGenix Recent Developments and Future Plans Figure 35. Global IFNG(Protein) Revenue Share by Players in 2020 Figure 36. IFNG(Protein) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure 37. Global Top 3 Players IFNG(Protein) Revenue Market Share in 2020 Figure 38. Global Top 10 Players IFNG(Protein) Revenue Market Share in 2020 Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021) Figure 40. Global IFNG(Protein) Revenue Share by Type in 2020 Figure 41. Global IFNG(Protein) Market Share Forecast by Type (2021-2026) Figure 42. Global IFNG(Protein) Revenue Share by Application in 2020 Figure 43. Global IFNG(Protein) Market Share Forecast by Application (2021-2026) Figure 44. North America IFNG(Protein) Sales Market Share by Type (2016-2026) Figure 45. North America IFNG(Protein) Sales Market Share by Application (2016-2026) Figure 46. North America IFNG(Protein) Revenue Market Share by Country (2016-2026) Figure 47. United States IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 48. Canada IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 49. Mexico IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 50. Europe IFNG(Protein) Sales Market Share by Type (2016-2026) Figure 51. Europe IFNG(Protein) Sales Market Share by Application (2016-2026) Figure 52. Europe IFNG(Protein) Revenue Market Share by Country (2016-2026) Figure 53. Germany IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 54. France IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 55. United Kingdom IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 56. Russia IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 57. Italy IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 58. Asia-Pacific IFNG(Protein) Sales Market Share by Type (2016-2026) Figure 59. Asia-Pacific IFNG(Protein) Sales Market Share by Application (2016-2026) Figure 60. Asia-Pacific IFNG(Protein) Revenue Market Share by Region (2016-2026) Figure 61. China IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 62. Japan IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 63. South Korea IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 64. India IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 65. Southeast Asia IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 66. Australia IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 67. South America IFNG(Protein) Sales Market Share by Type (2016-2026) Figure 68. South America IFNG(Protein) Sales Market Share by Application (2016-2026) Figure 69. South America IFNG(Protein) Revenue Market Share by Country (2016-2026) Figure 70. Brazil IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 71. Argentina IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 72. Middle East and Africa IFNG(Protein) Sales Market Share by Type (2016-2026) Figure 73. Middle East and Africa IFNG(Protein) Sales Market Share by Application (2016-2026) Figure 74. Middle East and Africa IFNG(Protein) Revenue Market Share by Country (2016-2026) Figure 75. Turkey IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 76. Saudi Arabia IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 77. UAE IFNG(Protein) Revenue and Growth Rate (2016-2026) & (USD Million) Figure 78. Methodology Figure 79. Research Process and Data Source